| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-10-2421 |
| P698 | PubMed publication ID | 21343391 |
| P50 | author | Pekka Kohonen | Q28651204 |
| Olli-Pekka Kallioniemi | Q29949182 | ||
| Päivi Östling | Q42777086 | ||
| Sara Kangaspeska | Q42808020 | ||
| Merja Perälä | Q42808466 | ||
| Suvi-Katri Leivonen | Q42808707 | ||
| Henrik Edgren | Q108557387 | ||
| P2093 | author name string | Anders Bjartell | |
| Yvonne Ceder | |||
| Anna Aakula | |||
| Rami Mäkelä | |||
| Anders Edsjö | |||
| Zandra Hagman | |||
| Daniel Nicorici | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| prostate cancer | Q181257 | ||
| P304 | page(s) | 1956-1967 | |
| P577 | publication date | 2011-02-22 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells | |
| P478 | volume | 71 |
| Q28573536 | A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells |
| Q39124868 | AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo |
| Q26795625 | Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer |
| Q52586103 | Androgen Receptor Is Inactivated and Degraded in Bladder Cancer Cells by Phenyl Glucosamine via miR-449a Restoration. |
| Q34199684 | Androgen receptor and its splice variants in prostate cancer |
| Q38946793 | Androgen receptor and miR-206 regulation in prostate cancer. |
| Q38175320 | Androgen receptor signaling in prostate cancer. |
| Q91676732 | Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer |
| Q38780007 | Androgen receptor-related diseases: what do we know? |
| Q36827512 | Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis |
| Q38931043 | BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence |
| Q28549191 | Cancer Biology, Toxicology and Alternative Methods Development Go Hand-in-Hand |
| Q51188744 | Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer. |
| Q90655532 | Characteristics of CXCL2 expression in coronary atherosclerosis and negative regulation by microRNA-421 |
| Q36774712 | Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs |
| Q47106096 | Circular RNAs: Isolation, characterization and their potential role in diseases |
| Q36951558 | Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals |
| Q42377108 | Clinical relevance of androgen receptor alterations in prostate cancer |
| Q92667802 | Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays |
| Q34871216 | Complex modulation of androgen responsive gene expression by methoxyacetic acid |
| Q38835737 | Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer |
| Q45949365 | Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate. |
| Q38833395 | DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects. |
| Q39219681 | Differential Effects of MicroRNAs on Glioblastoma Growth and Migration |
| Q38620609 | Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells |
| Q37707636 | Differential microRNA expression is associated with androgen receptor expression in breast cancer |
| Q42040180 | Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25. |
| Q37139536 | Effective classification of microRNA precursors using feature mining and AdaBoost algorithms |
| Q42002131 | Epigenetic impacts of ascorbate on human metastatic melanoma cells |
| Q36001910 | Epigenetic regulation of prostate cancer |
| Q39227406 | Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression |
| Q35744695 | Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment |
| Q37629548 | Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy |
| Q38628753 | Epithelial-mesenchymal transition in prostatic disease |
| Q39278878 | Estrogen-induced upregulation and 3'-UTR shortening of CDC6 |
| Q37139070 | Experimental evidence of persistent androgen-receptor-dependency in castration-resistant prostate cancer |
| Q33755160 | Exploiting Epigenetic Alterations in Prostate Cancer |
| Q94527009 | Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer |
| Q49718123 | Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells. |
| Q38323461 | Functional significance of aberrantly expressed microRNAs in prostate cancer |
| Q38518046 | Gene interference strategies as a new tool for the treatment of prostate cancer |
| Q35024073 | High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth |
| Q34455289 | Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a. |
| Q36147506 | Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening |
| Q101149163 | Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis |
| Q38964798 | Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling |
| Q37553695 | LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer |
| Q36146986 | MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells |
| Q52727349 | Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer. |
| Q38914799 | MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer |
| Q35809301 | MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets |
| Q53817952 | MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells. |
| Q34501681 | MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo |
| Q36878791 | MiR-654-5p attenuates breast cancer progression by targeting EPSTI1. |
| Q60421653 | MicroRNA Regulation of Endocrine Functions in the Ovary |
| Q41885247 | MicroRNA Regulatory Networks Provide Feedback Mechanisms for Steroid Receptor Signaling |
| Q30859743 | MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples |
| Q37113174 | MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery |
| Q57297931 | MicroRNA expression profile of urinary exosomes in Type IV lupus nephritis complicated by cellular crescent |
| Q42176056 | MicroRNA expression profiling in canine prostate cancer |
| Q36863089 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma |
| Q41136545 | MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth |
| Q34948292 | MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells |
| Q34444017 | MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells |
| Q36959452 | MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells |
| Q91666392 | MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways |
| Q35861506 | MicroRNAs and Androgen Receptor 3' Untranslated Region: A Missing Link in Castration-resistant Prostate Cancer? |
| Q38205266 | MicroRNAs and drug resistance in prostate cancers |
| Q37981157 | MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer |
| Q27008271 | MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans |
| Q64086166 | Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3 |
| Q38785291 | Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region. |
| Q26739708 | Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer |
| Q39347196 | Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining. |
| Q37737611 | Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer |
| Q90547055 | Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer |
| Q35097232 | Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway |
| Q26774456 | Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism |
| Q38667234 | Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications |
| Q42122998 | Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients. |
| Q41418045 | Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling |
| Q49530055 | Oxibendazole inhibits prostate cancer cell growth |
| Q34468270 | PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. |
| Q34425208 | Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression |
| Q58786195 | Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells |
| Q39043458 | Prognostic value of cross-omics screening for kidney clear cell renal cancer survival |
| Q53345311 | RETRACTED ARTICLE: Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma |
| Q38867413 | Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b |
| Q36439912 | Regulators of gene expression as biomarkers for prostate cancer |
| Q61807597 | Regulatory effect of miR-421 on humeral fracture and heterotopic ossification in elderly patients |
| Q39516113 | Resveratrol and prostate cancer: promising role for microRNAs |
| Q38702262 | Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer |
| Q36844904 | Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience |
| Q38086009 | Roles of microRNAs during prostatic tumorigenesis and tumor progression |
| Q64284476 | Screening of Recurrence Related MicroRNA in Ductal Carcinoma and Functional Study of MicroRNA-654-5p |
| Q46051382 | Seasonal variation of urinary microRNA expression in male goats (Capra hircus) as assessed by next generation sequencing. |
| Q41552623 | Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression |
| Q34606029 | Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype |
| Q37629551 | Stromal Androgen Receptor in Prostate Cancer Development and Progression |
| Q36067934 | Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer |
| Q36575243 | Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer. |
| Q31008419 | The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data description |
| Q37009376 | The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP. |
| Q38710305 | The Potential of MicroRNAs as Prostate Cancer Biomarkers. |
| Q37211907 | The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma |
| Q38109474 | The genomic landscape of prostate cancer |
| Q28468629 | The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer |
| Q38210767 | The p53/miR-34 axis in development and disease |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q38881373 | The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior. |
| Q64958587 | The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review. |
| Q38859577 | The roles of microRNAs in the progression of castration-resistant prostate cancer |
| Q39114252 | The tumour suppressor miR-34c targets MET in prostate cancer cells |
| Q52715350 | Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells. |
| Q39258781 | Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells |
| Q27014171 | Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer |
| Q43068000 | miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6. |
| Q38875539 | miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis |
| Q39168818 | miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients |
| Q39332346 | miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33 |
| Q36293209 | miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. |
| Q30580665 | miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data |
| Q39220695 | miRNA in Prostate Cancer: New Prospects for Old Challenges |
| Q91950745 | microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation |
Search more.